, LaPointe MC .. Inducible regulation of human brain natriuretic peptide promoter in transgenic mice./Am J Physiol Heart Circ Physiol.- 2001; № 280.P.: 368-376.
. Hosoda K., Nakao K., Mukoyama M., Saito Y., Jougasaki M., Shirakami G., et al. Expression of brain natriuretic peptide gene in human heart./Hypertension - 1991; № 17.P.: 1152-1156.
. Huang W., Lee M., Perng H., Yang S., Kuo S., Chang H.. Circulating brain natriuretic peptide values ??in healthy men before and after exercise./Metabolism.- 2002; 51. P.: 1423-1425.
. Hughes D., Talwar S., Squire IB, Davies JE, Ng LL. An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. / Clin. Sci.- 1999; 96.P.: 373-380.
. Kambayashi Y., Nakao K., Mukoyama M., Saito Y., Ogawa Y., Shiono S., et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium./FEBS. Lett.- 1990; 259. P.: 341-345.
. Kita T., Kida O., Yokota N., Eto T., Minamino N., Kangawa K., et al. Effect of brain natriuretic peptide - 45, a circulating form of brain natriuretic peptide, in spontaneously hypertensive rats./Eur. J. Pharmacol.- 1991; 202. P.: 73-79.
. Kohno M., Yokokawa K., Yasunari K. et al. Changes in plasma cardiac natriuretic peptide concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy / / Int. J. Clin. Pharmacol. Ther.- 1997; 35. P.: 38-42
. Levin ER., Gardner DG., Samson WK .. Natriuretic peptides./N. Engl. J. Med.- 1998; 339. P.: 321-328.
21. Maack, T. The broad homeostatic role of natriuretic peptides. / Arq Bras Endocrinol Metabol 50 , - 2006. P. :198-207.
22. Mair J., Hammerer-Lercher A., ??Puschendorf B.. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure./Clin. Chem. Lab. Med.- 2001; 39.P.: 571-88.
. Matsukawa N., Grzesik WJ., Takahashi N., Pandey KN., Pang S., Yamauchi M., Smithies O.. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system./Proc. Natl. Acad. Sci. / / USA - 1999; 96.P.: 7403-7408.
. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide./J. Clin. Invest.- 1991; 87.P.: 1402-1412.
. Nakao K., Ogawa Y., Suga S., Imura H.. Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors./J. Hypertens.- 1992; № 10.P.: 4-11
. Nakao K., Ogawa Y., Suga S., Imura H.. Molecular biology and biochemistry of the natriuretic peptide system./I: Natriuretic peptides. J. Hypertens.- 1992; № 10.P.: 907-912.
. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine testing and comparison to BNP./Eur. J. Heart. Fail.- 2004; № 6.P.: 289-293.
. Potter LR., Hunter T.. Guanylyl cyclase-li...
